title: [Clinical observation of TP regiment for treating refractory and terminal squamous cancer of the esophagus].
authors.affiliation: Department of Oncology, First Affiliated Hospital of Henan University, Kaifeng 475001, China. yangymch@sina.com
authors.forename: Yi-ming
authors.initials: YM
authors.lastname: Yang
authors.forename: Shui-lan
authors.initials: SL
authors.lastname: Zhang
authors.forename: Hua-yong
authors.initials: HY
authors.lastname: Song
authors.forename: Xu
authors.initials: X
authors.lastname: Li
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel; D043823:Taxoids / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D043823:Taxoids; D017239:Paclitaxel; D002945:Cisplatin